From Prehabilitation to Rehabilitation (Prehab2Rehab): Digitally Supported Short-Term Prehabilitation Prior to Cardiac Surgery
Prehab2Rehab
1 other identifier
interventional
40
1 country
1
Brief Summary
Prehab2Rehab is a prospective single-arm feasibility study evaluating the implementation of a multimodal, digitally supported prehabilitation program for adults awaiting elective cardiac surgery. During the routine preoperative waiting period, participants receive individualized education, psychosocial support, nutritional counselling, home-based physical activity guidance, and digital self-management support. The study aims to determine the feasibility, acceptability, usability, and safety of integrating this multidisciplinary prehabilitation pathway into routine clinical care. Exploratory outcomes include functional capacity, psychological well-being, nutritional status, digital engagement, and selected perioperative clinical outcomes to inform the design of future confirmatory trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2026
CompletedFirst Posted
Study publicly available on registry
July 21, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2027
July 24, 2026
July 1, 2026
9 months
July 16, 2026
July 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Proportion of eligible patients providing written informed consent (Recruitment rate)
Proportion of eligible patients who provide written informed consent and are enrolled in the study.
From study initiation until completion of recruitment (approximately 6 months)
Proportion of enrolled participants completing the study (Participant retention)
Proportion of enrolled participants who complete the prehabilitation program and scheduled study assessments through follow-up.
From baseline until completion of follow-up after Phase II cardiac rehabilitation (approximately 4-6 months)
Proportion of completed intervention components (Adherence to the prehabilitation program)
Participant adherence to the planned intervention components, including educational sessions, psychosocial support, nutritional counselling, home-based physical activity guidance, and use of digital support tools, assessed using attendance records and digital activity logs.
Throughout the preoperative intervention period (approximately 6-10 weeks)
Proportion of completed study assessments and available study data (Data completeness)
Proportion of planned study assessments, questionnaires, and clinical data successfully completed at each scheduled assessment time point.
From baseline until completion of follow-up after Phase II cardiac rehabilitation (approximately 4-6 months)
Participant-reported usability and acceptability scores for the digital support tools
Participant-reported usability and acceptability of the digital applications used during the prehabilitation program, assessed using a study-specific evaluation questionnaire and digital usage metrics.
At the preoperative assessment following completion of the prehabilitation program (approximately 6-10 weeks after baseline)
Number, severity, and type of intervention-related adverse events
Number, severity, and type of intervention-related adverse events occurring during participation in the prehabilitation program.
From enrolment until completion of the prehabilitation program (approximately 6-10 weeks)
Study Arms (1)
Digitally Supported Prehabilitation
EXPERIMENTALParticipants receive a personalized, multimodal, digitally supported prehabilitation program during the routine preoperative waiting period before elective cardiac surgery. The program includes patient education, psychosocial support, nutritional counselling, individualized home-based physical activity guidance, and digital self-management support in addition to routine clinical care.
Interventions
The Prehab2Rehab intervention is a personalized, multimodal, digitally supported prehabilitation program delivered during the routine 6-10 week preoperative waiting period before elective cardiac surgery. The program includes structured patient education, psychosocial support, nutritional assessment and counselling, individualized home-based physical activity guidance (including aerobic exercise, resistance training, breathing exercises, and inspiratory muscle training), and digital tools to support education, communication, self-management, and documentation. The intervention is delivered by a multidisciplinary team and complements routine perioperative care without altering standard clinical management.
Eligibility Criteria
You may qualify if:
- \- Age ≥ 18 years
- Classification as New York Heart Association (NYHA) functional class I-II
- Low surgical risk profile, defined as a EuroSCORE between 0 and 3
- Scheduled for one of the following elective cardiac surgical procedures:
- Open-heart valve surgery
- Coronary artery bypass grafting (CABG)
- Combined valve surgery and CABG
- Surgical closure of an atrial septal defect (ASD)
- Primary residence in Vienna to ensure the feasibility of in-person assessments and supervised sessions
- Sufficient German language proficiency to participate in assessments and educational components
- Adequate digital literacy to engage with the digital support tools used in the intervention
- Clinical and physical assessment confirming that participation in exercise training is medically safe
You may not qualify if:
- Emergency, urgent, or otherwise non-elective cardiac surgery
- Highly complex or specialized surgical procedures (e.g., aortic aneurysm repair, cardiac tumor resections)
- Interventional cardiac procedures (e.g., transcatheter aortic valve implantation \[TAVI\], MitraClip interventions)
- Neuromotor or physical impairments that might prevent adherence to the study protocol or informed participation
- Contraindications to spiroergometry according to current guidelines:
- Absolute contraindications:
- Acute coronary syndrome
- Symptomatic cardiac arrhythmias and/or hemodynamic instability
- Decompensated heart failure
- Acute pulmonary embolism
- Acute endocarditis, myocarditis, or pericarditis
- Febrile infections
- Acute deep vein thrombosis of the lower extremities
- Relative contraindications:
- Left main coronary artery stenosis
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Vienna
Vienna, State of Vienna, 1090, Austria
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2026
First Posted
July 21, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
October 31, 2027
Last Updated
July 24, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made publicly available because of privacy and data protection regulations (GDPR) and the small sample size, which may increase the risk of participant identification. Aggregated study results will be reported in scientific publications.